Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;23(6):1195-1198.
doi: 10.1016/j.jcf.2023.11.006. Epub 2023 Nov 18.

Olfactory loss in people with cystic fibrosis: Community perceptions and impact

Jessa E Miller  1 , Christine M Liu  2 , Edith T Zemanick  3 , Jason C Woods  4 , Christopher H Goss  5 , Jennifer L Taylor-Cousar  6 , Daniel M Beswick  7
Affiliations

Olfactory loss in people with cystic fibrosis: Community perceptions and impact

Jessa E Miller et al. J Cyst Fibros. 2024 Nov.

Abstract

Background: Olfactory dysfunction (OD) is prevalent in people with cystic fibrosis (PwCF) and can negatively impact quality-of-life (QOL). This study evaluated perceptions of OD, investigated how OD impacts QOL, and assessed willingness to participate in OD research among the CF community.

Methods: A 21-question survey was distributed through the CF Foundation's Community Voice program in 2023. The survey included questions on olfaction and interest in research. The Brief Questionnaire of Olfactory Disorders (BQOD), a validated person-reported outcome measure to assess QOL, was included.

Results: Seventy-six responses were received. Overall, 91% (69/76) reported olfactory problems. Mean BQOD score was 5.0 (standard deviation=4.8), indicating olfactory QOL impairment was present. Ninety-five percent (72/76) reported research on OD is worthwhile and were willing to participate in research.

Conclusion: Among PwCF, OD and olfactory-specific QOL impairments are prevalent. There is strong interest and willingness to participate in OD research among the CF community.

Keywords: Cystic fibrosis; Olfaction; Olfactory dysfunction; Quality of life; Smell.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest JEM: none. CML: NIDCD grant related to this work. ETZ: In the last 36 months, she has received grants to her institution from the Cystic Fibrosis Foundation, National Institutes of Health, and Vertex Pharmaceuticals Incorporated; has received fees from the Cystic Fibrosis Foundation and Vertex Pharmaceuticals Incorporated related to consultation, participation on advisory boards, and grant review committees. She served as chair of the CFF Therapeutics Development Network steering committee, reviewed grants for CF Canada, and received travel support from the European CF Society Clinical Trials Network for speaking at their annual meeting. JMW: In the last 36 months, he has received grants to her institution from the Cystic Fibrosis Foundation, the National Institutes of Health, Vertex Pharmaceuticals Incorporated; has received fees from Polarean LLC related to consultation on clinical and translational research. CHG: In the last 36 months, he has received grants from the National Institutes of Health, the Cystic Fibrosis Foundation, the Federal Drug Administration; has received fees from Enterprise Therapeutics for providing clinical trial design advice. He received honoraria from Gilead Sciences to serve as grant review committee chair and from Vertex Pharmaceuticals for speaking at the UK LEAD conference. He served as a DSMB Chair for a trial supported by Novartis and the European Commission. He serves as the Deputy Editor of the Annals of the American Thoracic Society. He has stock in Air Therapeutics. JLTC: In the last 36 months, she has received grants to her institution from the Cystic Fibrosis Foundation, the National Institutes of Health, Vertex Pharmaceuticals Incorporated, Eloxx, and 4DMT; has received fees from Vertex Pharmaceuticals Incorporated related to consultation on clinical research design, participation on advisory boards, and speaking engagements; and has served on advisory boards and/or provided clinical trial design consultation for Insmed, 4DMT, and AbbVie. She served on a DMC for AbbVie. She serves as the adult patient care representative to the CFF Board of Trustees, and on the CF Foundation's Clinical Research Executive Committee, Clinical Research Advisory Board, as immediate past chair of the CF TDN's Sexual Health, Reproduction and Gender Research Working Group, and as Co-Chair of the Heath Equity Team Science Awards study section. She also serves on the scientific advisory board for Emily's Entourage, and on the ATS Respiratory Health Awards Working Group and as Chair-Elect of the International Conference Committee. She is an Associate Editor for the Journal of Cystic Fibrosis and a member of the International Advisory Board for the Lancet Respiratory Medicine Journal. She serves on the Clinical Trials Review (CTLR) Study section for the National Institutes of Health/National Heart. Blood, Lung Institute. DMB: In the last 36 months, DMB has received grant support from CF Foundation related to this work as well as unrelated to this work. Unrelated to this work, DMB has received grant support from the International Society of Inflammation and Allergy of the Nose and the Sue Ann and John L. Weinberg Foundation, honoraria, and consulting fees on medicolegal cases and at Garner Health (equity).

References

    1. Patel ZM, Holbrook EH, Turner JH, et al. International consensus statement on allergy and rhinology: Olfaction. Int Forum Allergy Rhinol. 2022;12(4):327–680. doi:10.1002/alr.22929 - DOI - PubMed
    1. Laing DG, Armstrong JE, Aitken M, et al. Chemosensory function and food preferences of children with cystic fibrosis. Pediatr Pulmonol. 2010;45(8):807–815. doi:10.1002/ppul.21261 - DOI - PubMed
    1. Di Lullo AM, Iacotucci P, Comegna M, et al. Cystic Fibrosis: The Sense of Smell. Am J Rhinol Allergy. 2020;34(1):35–42. doi:10.1177/1945892419870450 - DOI - PubMed
    1. Beswick D, Humphries S, Balkissoon CD, et al. Olfactory Dysfunction in People with Cystic Fibrosis with at least One Copy of F508del. Int Forum Allergy Rhinol. - PMC - PubMed
    1. Sivam A, Wroblewski KE, Alkorta-Aranburu G, et al. Olfactory Dysfunction in Older Adults is Associated with Feelings of Depression and Loneliness. CHEMSE. 2016;41(4):293–299. doi:10.1093/chemse/bjv088 - DOI - PMC - PubMed